| Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer J Shi, Y Wang, L Zeng, Y Wu, J Deng, Q Zhang, Y Lin, J Li, T Kang, M Tao, ... Cancer cell 25 (2), 210-225, 2014 | 492 | 2014 |
| Toll-like receptor 3 and geographic atrophy in age-related macular degeneration Z Yang, C Stratton, PJ Francis, ME Kleinman, PL Tan, D Gibbs, Z Tong, ... New England Journal of Medicine 359 (14), 1456-1463, 2008 | 288 | 2008 |
| A new shrinkage estimator for dispersion improves differential expression detection in RNA-seq data H Wu, C Wang, Z Wu Biostatistics 14 (2), 232-243, 2013 | 273 | 2013 |
| Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer C Dong, Y Wu, Y Wang, C Wang, T Kang, PG Rychahou, YI Chi, BM Evers, ... Oncogene 32 (11), 1351-1362, 2013 | 243 | 2013 |
| Gene set enrichment analysis made simple RA Irizarry, C Wang, Y Zhou, TP Speed Statistical methods in medical research 18 (6), 565-575, 2009 | 242 | 2009 |
| The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells Y Wu, Y Wang, XH Yang, T Kang, Y Zhao, C Wang, BM Evers, BP Zhou Cell reports 5 (1), 224-236, 2013 | 199 | 2013 |
| Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer YA Wen, X Xiong, YY Zaytseva, DL Napier, E Vallee, AT Li, C Wang, ... Cell death & disease 9 (3), 265, 2018 | 177 | 2018 |
| Steroid Deficiency Syndromes in Mice with Targeted Disruption of Cyp11a1 MC Hu, NC Hsu, NB El Hadj, CI Pai, HP Chu, CKL Wang, B Chung Molecular endocrinology 16 (8), 1943-1950, 2002 | 175 | 2002 |
| Bayesian effect estimation accounting for adjustment uncertainty C Wang, G Parmigiani, F Dominici Biometrics 68 (3), 661-671, 2012 | 156 | 2012 |
| NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data H Wang, C Horbinski, H Wu, Y Liu, S Sheng, J Liu, H Weiss, AJ Stromberg, ... Nucleic acids research 44 (20), e151-e151, 2016 | 140 | 2016 |
| RORα suppresses breast tumor invasion by inducing SEMA3F expression G Xiong, C Wang, BM Evers, BP Zhou, R Xu Cancer research 72 (7), 1728-1739, 2012 | 128 | 2012 |
| Functions of the Upstream and Proximal Steroidogenic Factor 1 (SF-1)-Binding Sites in the CYP11A1 Promoter in Basal Transcription and Hormonal Response MC Hu, NC Hsu, CI Pai, CKL Wang, B Chung Molecular Endocrinology 15 (5), 812-818, 2001 | 126 | 2001 |
| Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation Y Wu, Y Wang, Y Lin, Y Liu, Y Wang, J Jia, P Singh, YI Chi, C Wang, ... Nature communications 8 (1), 14228, 2017 | 125 | 2017 |
| PROPER: comprehensive power evaluation for differential expression using RNA-seq H Wu, C Wang, Z Wu Bioinformatics 31 (2), 233-241, 2015 | 104 | 2015 |
| Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer YY Zaytseva, PG Rychahou, AT Le, TL Scott, RM Flight, JT Kim, J Harris, ... Oncotarget 9 (37), 24787, 2018 | 100 | 2018 |
| EttA regulates translation by binding the ribosomal E site and restricting ribosome-tRNA dynamics B Chen, G Boël, Y Hashem, W Ning, J Fei, C Wang, RL Gonzalez Jr, ... Nature structural & molecular biology 21 (2), 152-159, 2014 | 97 | 2014 |
| Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors JT Kim, J Li, ER Jang, P Gulhati, PG Rychahou, DL Napier, C Wang, ... Carcinogenesis 34 (5), 953-961, 2013 | 95 | 2013 |
| PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice X Li, PD Stevens, J Liu, H Yang, W Wang, C Wang, Z Zeng, MD Schmidt, ... Gastroenterology 146 (5), 1301-1312. e10, 2014 | 93 | 2014 |
| Mechanisms of apoptosis by the tumor suppressor Par‐4 N Hebbar, C Wang, VM Rangnekar Journal of cellular physiology 227 (12), 3715-3721, 2012 | 93 | 2012 |
| p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer J Liu, D He, L Cheng, C Huang, Y Zhang, X Rao, Y Kong, C Li, Z Zhang, ... Oncogene 39 (19), 3939-3951, 2020 | 86 | 2020 |
